Cytokine and Inducible Nitric Oxide Synthase mRNA Expression during Experimental Murine Cryptococcal Meningoencephalitis

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 2338-2349

  Maffei, Claudia M L ^a,b,c,d   Mirels, Laurence F ^b,c,d   Sobel, Raymond A ^d,e   Clemons, Karl V ^b,c,d   Stevens, David A ^b,c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PROTEIN P40; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRYPTOCOCCAL MENINGOENCEPHALITIS; CRYPTOCOCCUS; EFFECTOR CELL; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MALE; MENINGOENCEPHALITIS; MOUSE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ANIMALS; BRAIN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MENINGITIS, CRYPTOCOCCAL; MENINGOENCEPHALITIS; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; SPLEEN;

EID: 1842431124     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.4.2338-2349.2004     Document Type: Article

References (58)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Almeida, G. M., R. M. Andrade, and C. A. Bento. 2001. The capsular polysaccharides of Cryptococcus neoformans activate normal CD4(+) T cells in a dominant Th2 pattern. J. Immunol. 167:5845-5851.
3. Ashman, R. B., E. M. Bolitho, and A. Fulurija. 1995. Cytokine mRNA in brain tissue from mice that show strain-dependent differences in the severity of lesions induced by systemic infection with Candida albicans yeast. J. Infect. Dis. 172:823-830.
4. Barluzzi, R., A. Brozzetti, D. Delfino, F. Bistoni, and E. Blasi. 1998. Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not of secretory functions. Med. Mycol. 36:189-197.
5. Barluzzi, R., A. Brozzetti, G. Mariucci, M. Tantucci, R. G. Neglia, F. Bistoni, and E. Blasi. 2000. Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, nonmelanogenic Cryptococcus neoformans strain. J. Neuroimmunol. 109:75-86.
6. Blasi, E., R. Barluzzi, R. Mazzolla, P. Mosci, and F. Bistoni. 1992. Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect. Immun. 60:3682-3688.
7. Blasi, E., R. Barluzzi, R. Mazzolla, L. Pitzurra, M. Puliti, S. Saleppico, and F. Bistoni. 1995. Biomolecular events involved in anticryptococcal resistance in the brain. Infect. Immun. 63:1218-1222.
8. Bocca, A. L., E. E. Hayashi, A. G. Pinheiro, A. B. Furlanetto, A. P. Campanelli, F. Q. Cunha, and F. Figueiredo. 1998. Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. J. Immunol. 161:3056-3063.
9. Brown, H., G. Turner, S. Rogerson, M. Tembo, J. Mwenechanya, M. Molyneux, and T. Taylor. 1999. Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180:1742-1746.
10. + T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect. Immun. 68:456-462.
11. Buchanan, K. L., and J. W. Murphy. 1998. What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4:71-83.
12. Clemons, K. V., R. Azzi, and D. A. Stevens. 1996. Experimental systemic cryptococcosis in SCID mice. J. Med. Vet. Mycol. 34:331-335.
13. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460-464.
14. Clemons, K. V., J. E. Lutz, and D. A. Stevens. 2001. Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice. Antimicrob. Agents Chemother. 45:686-689.
15. Decken, K., G. Kohler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber. 1998. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:4994-5000.
16. Deckert, M., S. Soltek, G. Geginat, S. Lutjen, M. Montesinos-Rongen, H. Hof, and D. Schluter. 2001. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 69:4561-4571.
17. Dobrick, P., K. Miksits, and H. Hahn. 1995. L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis. Mycopathologia 131:159-166.
18. Gilliland, G., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725-2729.
19. Hoag, K. A., M. F. Lipscomb, A. A. Izzo, and N. E. Street. 1997. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17:733-739.
20. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487-495.
21. Hoeprich, P., and P. Finn. 1972. Obfuscation of the activity of antifungal antimicrobics by culture media. J. Infect. Dis. 126:353-361.
22. Hollander, M., and D. A. Wolfe. 1973. Nonparametric statistical methods. Wiley, New York, N.Y.
23. Huffnagle, G. B., and M. F. Lipscomb. 1998. Cells and cytokines in pulmonary cryptococcosis. Res. Immunol. 149:387-396.
24. Huffnagle, G. B., M. F. Lipscomb, J. A. Lovchik, K. A. Hoag, and N. E. Street. 1994. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol. 55:35-42.
25. Huffnagle, G. B., and L. K. McNeil. 1999. Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J. Neurovirol. 5:76-81.
26. Huffnagle, G. B., R. M. Strieter, L. K. McNeil, R. A. McDonald, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1997. Macrophage inflammatory protein-1a (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318-327.
27. Hunter, C. A., J. S. Abrams, M. H. Beaman, and J. S. Remington. 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect. Immun. 61:4038-4044.
28. Kawakami, K., M. Tohyama, X. Qifeng, and A. Saito. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1307-1312.
29. Klein, S. A., O. G. Ottmann, K. Ballas, T. S. Dobmeyer, M. Pape, E. Weidmann, D. Hoelzer, and U. Kalina. 1999. Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction. Cytokine 11:451-458.
30. Lee, S. C., D. W. Dickson, C. F. Brosnan, and A. Casadevall. 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:365-369.
31. Lee, S. C., Y. Kress, M. L. Zhao, D. W. Dickson, and A. Casadevall. 1995. Cryptococcus neoformans survive and replicate in human microglia. Lab. Investig. 73:871-879.
32. Lee, S. C., W. Liu, D. W. Dickson, C. F. Brosnan, and J. W. Berman. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150:2659-2667.
33. Licinio, J., P. Prolo, S. M. McCann, and M. L. Wong. 1999. Brain iNOS: current understanding and clinical implications. Mol. Med. Today 5:225-232.
34. Licinio, J., and M. L. Wong. 1997. Pathways and mechanisms for cytokine signaling of the central nervous system. J. Clin. Investig. 100:2941-2947.
35. Loddick, S. A., M. L. Wong, P. B. Bongiorno, P.W. Gold, J. Licinio, and N. J. Rothwell. 1997. Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem. Biophys. Res. Commun. 234:211-215.
36. Lortholary, O., L. Improvisi, N. Rayhane, F. Gray, C. Fitting, J. M. Cavaillon, and F. Dromer. 1999. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect. Immun. 67:6314-6320.
37. Lutz, J. E., K. V. Clemons, and D. A. Stevens. 2000. Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis. J. Antimicrob. Chemother. 46:437-442.
38. Monari, C., T. R. Kozel, A. Casadevall, D. Pietrella, B. Palazzetti, and A. Vecchiarelli. 1999. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans. Immunology 98:27-35.
39. Monari, C., C. Retini, B. Palazzetti, F. Bistoni, and A. Vecchiarelli. 1997. Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans. Clin. Exp. Immunol. 109:242-247.
40. Murphy, J. W. 1998. Protective cell-mediated immunity against Cryptococcus neoformans. Res. Immunol. 149:373-386.
41. Pietrella, D., R. Cherniak, C. Strappini, S. Perito, P. Mosci, F. Bistoni, and A. Vecchiarelli. 2001. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect. Immun. 69:2808-2814.
42. Polak, J., and S. V. Noorden. 1997. Introduction to immunocytochemistry, 2nd ed. Springer-Verlag, Inc., New York, N.Y.
43. Qureshi, M. H., T. Zhang, Y. Koguchi, K. Nakashima, H. Okamura, M. Kurimoto, and K. Kawakami. 1999. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur. J. Immunol. 29:643-649.
44. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37-46.
45. Retini, C., A. Vecchiarelli, C. Monari, F. Bistoni, and T. R. Kozel. 1998. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes. Infect. Immun. 66:664-669.
46. Retini, C., A. Vecchiarelli, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 64:2897-2903.
47. Romagnani, S. 1996. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 80:225-235.
48. Stalder, A. K., A. Pagenstecher, N. C. Yu, C. Kincaid, C. S. Chiang, M. V. Hobbs, F. E. Bloom, and I. L. Campbell. 1997. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J. Immunol. 159:1344-1351.
49. Stevens, D. A., T. J. Walsh, F. Bistoni, E. Cenci, K. V. Clemons, G. Del Sero, C. Fe d'Ostiani, B. J. Kullberg, A. Mencacci, E. Roilides, and L. Romani. 1998. Cytokines and mycoses. Med. Mycol. 36(Suppl. 1):174-182.
50. Suzuki, Y., S. Fujii, T. Tominaga, T. Yoshimoto, T. Akaike, H. Maeda, and T. Yoshimura. 1999. Direct evidence of in vivo nitric oxide production and inducible nitric oxide synthase mRNA expression in the brain of living rat during experimental meningitis. J. Cereb. Blood Flow Metab. 19:1175-1178.
51. Turka, L. A., R. E. Goodman, J. L. Rutkowski, A. A. Sima, A. Merry, R. S. Mitra, T. Wrone-Smith, G. Toews, R. M. Strieter, and B. J. Nickoloff. 1995. Interleukin 12: a potential link between nerve cells and the immune response in inflammatory disorders. Mol. Med. 1:690-699.
52. Vecchiarelli, A. 2000. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38:407-417.
53. Vecchiarelli, A., C. Retini, C. Monari, and A. Casadevall. 1998. Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation. Infect. Immun. 66:1244-1247.
54. Vecchiarelli, A., C. Retini, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:2846-2849.
55. Vitkovic, L., J. Bockaert, and C. Jacque. 2000. "Inflammatory" cytokines: neuromodulators in normal brain? J. Neurochem. 74:457-471.
56. Wolf, S. F., D. Sieburth, and J. Sypek. 1994. Interleukin 12: a key modulator of immune function. Stem Cells 12:154-168.
57. Xiao, B. G., and H. Link. 1998. Immune regulation within the central nervous system. J. Neurol. Sci. 157:1-12.
58. Zhou, N. M., P. Matthys, C. Polacek, P. Fiten, A. Sato, A. Billiau, and G. Froyen. 1997. A competitive RT-PCR method for the quantitative analysis of cytokine mRNAs in mouse tissues. Cytokine 9:212-218.